Premium
ONGOING STUDY OF OBINUTUZUMAB SHORT DURATION INFUSION IN PATIENTS WITH PREVIOUSLY UNTREATED ADVANCED FOLLICULAR LYMPHOMA
Author(s) -
Canales M.,
Mason J.,
Hernandez J.,
Tomiczek M.,
Hübel K.
Publication year - 2019
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.19_2632
Subject(s) - obinutuzumab , medicine , follicular lymphoma , tolerability , lymphoma , rituximab , follicular phase , oncology , adverse effect